跳至主要内容
临床试验/EUCTR2011-002236-92-NL
EUCTR2011-002236-92-NL进行中(未招募)1 期

Dopamine on top of standard treatment for patients with exacerbation of Heart Failure, at home situation - Do-HF

Maatschap cardiologie Isala klinieken Zwolle0 个研究点目标入组 110 人开始时间: 2011年6月14日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Exacerbation heart failure with NYHA class III-IV
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 80

排除标准

  • Cardiogenic shock
  • Tachycardia, heart rate > 100 bpm
  • Indication for hospitalization
  • Severe aortic valve stenosis
  • Severe hepatic or renal disease
  • Patients with acute coronary syndromes
  • Previous participation in the study
  • Life expectancy of < 1 year
  • Absolute contra indication for the use of Dopamine
  • Women of child-bearing potential
  • Unable to provide informed consent

研究者

发起方
Maatschap cardiologie Isala klinieken Zwolle

相似试验

Dopamine on top of standard treatment for patients ... | 临床试验